Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Oncology Institute Inc shares valued at $2,054,712 were sold by M33 Growth I L.P. on Jun 05 ’25. At $3.05 per share, M33 Growth I L.P. sold 673,676 shares. The insider’s holdings dropped to 13,950,557 shares worth approximately $45.06 million following the completion of this transaction.
Also, M33 Growth I L.P. sold 76,324 shares, netting a total of over 232,788 in proceeds. Following the sale of shares at $3.05 each, the insider now holds 1,272,724 shares.
Before that, Hively Brad had sold 1,976,137 shares from its account. In a trade valued at $5,672,106, the Director traded Oncology Institute Inc shares for $2.87 each. Upon closing the transaction, the insider’s holdings decreased to 1,976,137 shares, worth approximately $1.95 million.
As published in their initiating research note from B. Riley Securities on July 16, 2025, Oncology Institute Inc [TOI] has been a Buy and the price target has been revised to $6. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. Earlier on September 14, 2022, Guggenheim initiated its rating. Their recommendation was “a Buy” for TOI stock.
Analyzing TOI Stock Performance
On last trading session,, Oncology Institute Inc [NASDAQ: TOI] rose 8.75% to $3.23. The stock’s lowest price that day was $3.1201, but it reached a high of $3.39 in the same session. During the last five days, there has been a surge of approximately 33.47%. Over the course of the year, Oncology Institute Inc shares have jumped approximately 587.23%. Shares of the company reached a 52-week high of $3.50 on 04/24/25 and a 52-week low of $0.25 on 01/10/25.
Support And Resistance Levels for Oncology Institute Inc (TOI)
According to the 24-hour chart, there is a support level at 3.10, which, if violated, would cause prices to drop to 2.98. In the upper region, resistance lies at 3.37. The next price resistance is at 3.52. RSI (Relative Strength Index) is 63.92 on the 14-day chart, showing neutral technical sentiment.
Is Oncology Institute Inc subject to short interest?
Stocks of Oncology Institute Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.54 million shares to 2.41 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 1.87 million shares. A jump of 22.34% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.11 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.11.
Which companies own the most shares of Oncology Institute Inc (TOI)?
In terms of Oncology Institute Inc share price expectations, FactSet research, analysts set an average price target of 8 in the next 12 months, up nearly 169.36% from the previous closing price of $2.97. Analysts anticipate Oncology Institute Inc stock to reach 10 by 2025, with the lowest price target being 6. In spite of this, 2 analysts ranked Oncology Institute Inc stock as Buy at the end of 2025. On August 15, 2022, Jefferies assigned a price target of “a Buy” to the stock and initiated coverage with a $10.
